Back |
home / stock / mygn / mygn message board
Subject | By | Source | When |
---|---|---|---|
Ouch what's going on here | gixxer11 | investorshub | 12/30/2013 2:54:52 PM |
riddock57: Myriad Genetics, Inc. (MYGN) Breast cancer is cancer that forms in cells of the breast. T | riddock57 | investorshangout | 12/15/2013 1:41:30 AM |
2 good news out , should get $MYGN | TheFinalCD | investorshub | 12/14/2013 8:29:40 PM |
Myriad's HRD(TM) Test Significantly Predicts Response to Cisplatin | TheFinalCD | investorshub | 12/14/2013 8:28:35 PM |
I like it! | Milo2 | investorshub | 12/13/2013 12:03:26 AM |
Myriad myRisk Hereditary Cancer(TM) Test Significantly Improves Detection | TheFinalCD | investorshub | 12/12/2013 11:14:37 PM |
AH 29+ cmon Monday! | ChartPoP | investorshub | 11/22/2013 9:44:01 PM |
tuff not to add at these 29's | kittzelle | investorshub | 11/22/2013 6:04:43 PM |
Likely a new high in the coming months, | surf1944 | investorshub | 11/22/2013 2:08:56 PM |
News, Short Squeeze, Breakout and More Instantly...
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To Work Certification for the second year in a row. The certification is based entirely on what curre...
2024-06-26 17:30:02 ET Scotiabank analyst issues OUTPERFORM recommendation for MYGN on June 26, 2024 04:14PM ET. MYGN was trading at $24.62 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Buy, 5 - Ho...
2024-06-26 17:00:11 ET Sung Ji Nam from Scotiabank issued a price target of $29.00 for MYGN on 2024-06-26 16:14:00. The adjusted price target was set to $29.00. At the time of the announcement, MYGN was trading at $24.62. The overall price target consensus is at $24.33 w...